ELANCO ANIMAL HLTH ($ELAN) posted quarterly earnings results for Q4 2025 on Tuesday, February 24th. The company reported earnings of $0.13 per share, beating estimates of $0.11 by $0.02. The company also reported revenue of $1,144,000,000, beating estimates of $1,114,797,096 by $29,202,904.
You can see Quiver Quantitative's $ELAN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ELANCO ANIMAL HLTH Insider Trading Activity
ELANCO ANIMAL HLTH insiders have traded $ELAN stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ELAN stock by insiders over the last 6 months:
- JEFFREY N SIMMONS (PRESIDENT, CEO AND DIRECTOR) purchased 22,000 shares for an estimated $478,495
- LAWRENCE ERIK KURZIUS purchased 10,000 shares for an estimated $213,000
- ROBERT M VANHIMBERGEN (EVP and CFO) purchased 6,950 shares for an estimated $150,426
- RAJEEV A. MODI (SEE REMARKS) purchased 4,500 shares for an estimated $95,984
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ELANCO ANIMAL HLTH Hedge Fund Activity
We have seen 262 institutional investors add shares of ELANCO ANIMAL HLTH stock to their portfolio, and 219 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 14,773,349 shares (-46.9%) from their portfolio in Q4 2025, for an estimated $334,320,887
- FMR LLC removed 13,161,059 shares (-20.1%) from their portfolio in Q4 2025, for an estimated $297,834,765
- UBS GROUP AG removed 7,795,304 shares (-47.3%) from their portfolio in Q4 2025, for an estimated $176,407,729
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 4,620,713 shares (-75.2%) from their portfolio in Q4 2025, for an estimated $104,566,735
- FREESTONE GROVE PARTNERS LP removed 3,841,422 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $86,931,379
- PRIMECAP MANAGEMENT CO/CA/ removed 3,744,068 shares (-7.5%) from their portfolio in Q4 2025, for an estimated $84,728,258
- INVESCO LTD. added 3,690,735 shares (+336.0%) to their portfolio in Q4 2025, for an estimated $83,521,333
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ELANCO ANIMAL HLTH Congressional Stock Trading
Members of Congress have traded $ELAN stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ELAN stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ELANCO ANIMAL HLTH Analyst Ratings
Wall Street analysts have issued reports on $ELAN in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Overweight" rating on 11/21/2025
- UBS issued a "Buy" rating on 11/06/2025
- JP Morgan issued a "Overweight" rating on 10/07/2025
- Stifel issued a "Buy" rating on 09/24/2025
To track analyst ratings and price targets for ELANCO ANIMAL HLTH, check out Quiver Quantitative's $ELAN forecast page.
ELANCO ANIMAL HLTH Price Targets
Multiple analysts have issued price targets for $ELAN recently. We have seen 7 analysts offer price targets for $ELAN in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Chris Schott from JP Morgan set a target price of $28.0 on 02/19/2026
- David Westenberg from Piper Sandler set a target price of $30.0 on 01/22/2026
- Erin Wright from Morgan Stanley set a target price of $22.0 on 12/18/2025
- Glen Santangelo from Barclays set a target price of $30.0 on 12/09/2025
- Steve Dechert from Keybanc set a target price of $27.0 on 11/21/2025
- Andrea Alfonso from UBS set a target price of $27.0 on 11/06/2025
- Jonathan Block from Stifel set a target price of $23.0 on 09/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
